Pharma Marketing 2010 - Frankfurt

North West Business Group30 September 2010, Frankfurt, Germany.
Pharma Marketing 2010 in Frankfurt provides a key platform for Europe's pharmaceutical industry stakeholders, such as yourself, to discover how best to tackle the key challenges of a price-sensitive and increasingly competitive and rapidly changing market.

This event offers the perfect setting for industry peers to present their ideas and successes directly to key decision makers from leading pharmaceutical companies. At this meeting you will meet and interact with senior level marketing executives, through a number of one-on-one meetings and networking activities.

They will discuss the challenges and strategies used to enhance online communication, customer relationship, strengthen brand awareness and improve profitability in marketing. This is your one-stop-shop to the most up to date online marketing strategies, regulatory low down, measuring ROI, analytical tools and more such as:

  • 5 reasons why Pharma should not do E-marketing
  • The successful commercialisation of a pharma brand start with an effective launch
  • Forecasting is easy, communication is difficult
  • Achieving Launch Excellence in a Challenging Pharma Marketplace
  • The Doctor - Patient - Pharma: a triangle about a patient's health improvement.
  • Balancing "old" and "new" marketing strategies
  • Brand Management
  • Why Online Belongs to the Pharma Marketing Mix

Joins some of the experts like:

  • IMS heath, Director commercial effectiveness EMEA
  • UCB Pharma, Head of eStrategies
  • Novartis Oncology Region Europe, Regional Brand Leader
  • Eli Lilly, Director Human Resources
  • Astellas Pharma,Marketing Director
  • Genzyme, Associate Director Global Commercial Effectiveness and Development
  • AstraZneca, VP Global Marketing
  • Allergan, Director Consumer Marketing
  • Google, Industry Head
  • And many more ...

Who should attend?
This conference is designed to attract key decision makers from the Pharmaceutical industry: Presidents, Managing Directors, Country Managers, General Managers, Vice Presidents, Regional Directors/ Heads, Directors, Department Heads, Managers.

For further information and registration, please visit:
http://nwbg.eu/all-events/pharma-marketing-2010/

Most Popular Now

Top 20 breaking World Pharma News of 2017

We are proud to announce the top 20 most popular breaking World Pharma News from 2017. Have a wonderful 2018 new(s) year filled with health, happiness, and spectacular su...

Novartis advances head-to-head superiority trials …

Novartis announced today the initiation of SURPASS, a head-to-head clinical trial of Cosentyx® (secukinumab) versus proposed biosimilar adalimumab** in ankylosing spondyl...

New research paper shows that AstraZeneca has achi…

In a research paper published today by Nature Reviews Drug Discovery(1), AstraZeneca's IMED Biotech Unit documents a more than four-fold improvement in R&D productivity f...

Diabetes drug 'significantly reverses memory loss…

A drug developed for diabetes could be used to treat Alzheimer's after scientists found it "significantly reversed memory loss" in mice through a triple method of action...

Sandoz regulatory submission for proposed biosimil…

Sandoz, a Novartis division and the global leader in biosimilar medicines, announced today that the US Food and Drug Administration (FDA) has accepted its Biologics Licen...

Zika remains a research and public health challeng…

Since 2016, when Zika was declared by the World Health Organization as a public health emergency of international concern, the virus has become established in more than 8...

Dirt-dwelling microbe produces potential anti-mela…

A type of soil-dwelling bacterium produces molecules that induce death in melanoma cells, research at Oregon State University shows. The molecule is a secondary metabolit...

Try exercise to improve memory, thinking

For patients with mild cognitive impairment, don't be surprised if your health care provider prescribes exercise rather than medication. A new guideline for medical pract...

FDA approves first treatment for breast cancer wit…

The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast can...

Novartis Kisqali® received FDA Breakthrough Therap…

Novartis today announced Kisqali® (ribociclib) received US Food and Drug Administration (FDA) Breakthrough Therapy designation for initial endocrine-based treatment of pr...

Novartis appoints Elizabeth Barrett as Oncology He…

Novartis announced today that Elizabeth (Liz) Barrett, currently Global President Oncology at Pfizer, Inc., has been appointed CEO Novartis Oncology and a member of the E...

Berry gives boost to cervical cancer therapy

According to the Centers for Disease Control and Prevention, approximately 12,000 women in the United States are diagnosed with cervical cancer each year. One of the most...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]